A new analysis of more than 4.2 million adults indicates that body-mass index (BMI) can overlook important signals of metabolic health.
Study Overview
Researchers examined participants between the ages of 35 and 75 and followed them for roughly five years. During that time they recorded incidents of heart disease, diabetes, cancer and chronic lung disease. The investigators also gathered data on a wide range of physical and biochemical markers.
Instead of relying on BMI alone, they compared 15 different measurements that capture body size, fat distribution and metabolic markers such as blood sugar and triglycerides. This broader set of variables allowed the team to test which ones were most closely linked to each disease outcome.
Key Findings by Condition
The analysis showed that no single measurement perfectly predicts any disease, but several outperformed BMI for particular outcomes. For cardiovascular events, an estimate of visceral fat provided the strongest association.
Visceral fat sits deep in the abdomen around organs and is linked to inflammation and insulin resistance, factors that raise heart-disease risk. In contrast, a combined score of triglycerides and blood-sugar levels identified diabetes risk more accurately than BMI.
A measure describing overall body shape correlated better with chronic lung disease, while none of the 15 metrics showed a clear advantage for spotting cancer risk.
Even the top-performing indicators offered only modest improvements over BMI, showing that risk prediction remains imperfect.
Given these modest gains, clinicians may begin to incorporate select metrics alongside BMI, especially as electronic health records make such data readily available. Wider adoption will likely hinge on guideline revisions and payer acceptance.
Practical Takeaways
Individuals can gain a clearer picture of metabolic health without expensive scans. Four readily available measures merit attention: waist circumference, blood pressure, fasting blood-sugar and cholesterol levels.
Broader Context
These findings add to a growing body of research that suggests a single index cannot capture the complexity of metabolic risk. Earlier work had hinted that fat distribution and blood-marker profiles each tell part of the story, and this new study confirms that view with a much larger sample.
Future Directions
Researchers plan to explore how combinations of the top-performing measures interact over time. Longitudinal follow-up could reveal whether changes in visceral-fat estimates or triglyceride-blood-sugar scores predict disease onset more accurately than a single snapshot.